BUILDERS

The episode has a few genuinely useful tactics - particularly the pre-product diagnostic analysis used to create urgency and cultivate early champions - but large portions consist of fairly standard B2B GTM advice (in-person selling, quality over quantity, subject matter expertise as brand). The insight-to-filler ratio is average for the genre.

“that analysis consisted of effectively a deep dive data science based diagnostic that our teams would provide as part of a one time artifact that we then present to these potential prospects, these stakeholders in sort of a, uh, McKinsey style or consulting style readout”

“we're not treating, you know, the relationships that we're developing as transactional ones. It's really based off of like how can we be accretive to, you know, the industry more generally”

The 'forgotten heroes' positioning for back-office revenue cycle staff is a genuinely interesting and calculated strategic insight. Most other content - subject matter expertise as brand, in-person selling, quality leads over volume - is well-worn B2B conventional wisdom that offers little new thinking.

“Those folks are almost like thought about second, third, fourth or oftentimes never thought about. And so our purpose in, you know, having language that puts kind of those forgotten heroes at like the center of what we do is a very, I think, calculated strategy”

“I think gimmickry kind of throwing out like, you know, free AirPods for example, for a booked meeting. Like those things don't work in health care”

Aman Magoon is a second-time founder who has clearly done the work himself - running diagnostic analyses, hosting summits, and closing enterprise healthcare deals. He's a relevant practitioner, not a career podcast guest, though the business appears early-stage and he doesn't speak from a position of massive scale.

“In our second business, we're actually resolving and taking action on, you know, the very complex nuances of insurance and how providers get paid”

“we do a lot of pre work to ensure that we're targeting the right accounts based off of what our core ICP is across those two segments”

There are some specific details - 2-3 week diagnostic development cycles, summit attendance growing from 10-15 to 100-150+, an 18-month internal close-rate analysis - but the most important claims lack hard numbers, and the headline result ('pretty staggering improvement') is frustratingly vague when it should be the most compelling data point.

“18 months into the business, we had done a bit of an analysis on what our kind of close one effectiveness was for clients that we met in person versus those that we didn't. And we saw that there was a, uh, pretty staggering improvement”

“those artifacts that we'd spend, you know, two to three weeks developing internally”

The host surfaces one genuinely productive prompt - zeroing in on the 'forgotten heroes' website framing - but otherwise asks generic opener questions, validates rather than probes, and misses obvious follow-ups (e.g., never asks for the actual close-rate numbers from the in-person analysis or the diagnostic conversion rate).

“It seems like in person is the theme. I hear that from everyone I talk to, regardless of if they're in healthcare or cybersecurity”

“I wonder if that works for anyone”